HAYWARD, Calif.--(BUSINESS WIRE)--Mar. 8, 2018--
Pulse Biosciences, Inc. (Nasdaq: PLSE), a medical technology company
developing a proprietary therapeutic tissue treatment based on its
Nano-Pulse Stimulation platform, today announced that the Company will
report fourth quarter and full year 2017 financial results and
operational highlights on Friday, March 16th, 2018. Pulse Biosciences
management will host a conference call and webcast at 4:30 p.m. Easte...